Investeringsoversigt

1469 investments

Titel Sort descending	Periode	Program
Development of a peptide-based CD133-targeting optical probe for image-guided cancer surgery	2020 - 2023	Industrial Researcher
Development of a peptide-based CD133-targeting optical probe for image-guided cancer surgery Period 2020 - 2023 Region Region Hovedstaden Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 100 Invested 1.2 mill. Budget 1.2 mill. Partners University of Copenhagen, FluoGuide A/S People FluoGuide A/S Read more about the project
Development of a platform for isolation of circulating tumor cells to improve early cancer detection and diagnosis.	2017 - 2020	Industrial Researcher
Development of a platform for isolation of circulating tumor cells to improve early cancer detection and diagnosis. Period 2017 - 2020 Region Region Hovedstaden Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 22.79 Invested 1.1 mill. Budget 4.7 mill. Partners University of Copenhagen, VarCT Diagnostics ApS People VarCT Diagnostics ApS Read more about the project
Development of a Raman spectroscopy based control system for the U-Loop fermentor	2016 - 2019	Industrial Researcher
Development of a Raman spectroscopy based control system for the U-Loop fermentor Period 2016 - 2019 Region Region Sjælland Program Erhvervsforsker Area Produktion, Materialer, Digitalisering og IKT Investment Percentage 40.67 Invested 1.1 mill. Budget 2.6 mill. Partners Technical University of Denmark, UNIBIO A/S People UNIBIO A/S Read more about the project
Development of a Single Cell RNA Sequencing platform for Bacteria to Delineate Antibiotic Hetero-resistance	2023 - 2026	Industrial Researcher
Development of a Single Cell RNA Sequencing platform for Bacteria to Delineate Antibiotic Hetero-resistance Period 2023 - 2026 Region Program Erhvervsforsker Area Ikke defineret Investment Percentage 60.7 Invested 1.1 mill. Budget 1.8 mill. Stafylokok-infektioner bliver ofte fejldiagnosticeret. Dette kan skyldes hetero-resistens hvor en bakteriepopulation udtrykker forskellige niveauer af resistens. I dag bliver subpopulationer af resistente bakterier sjældent opdaget under diagnostikken, hvilket kan resultere i fatal fejlbehandling. Derfor vil vi udforske denne niche kommercielt ved at udvikle en molekylær enkelt celle sekventeringsplatform til bakterielt RNA og hermed muliggøre udvikling af nøjagtige diagnostiske tests. Partners University of Copenhagen, AMPLEXA GENETICS A/S People Read more about the project
Development of a single photon source at telecom wavelength	2024 - 2027	Industrial Researcher
Development of a single photon source at telecom wavelength Period 2024 - 2027 Region Program Erhvervsforsker Area Ikke defineret Investment Percentage 44.15 Invested 1.1 mill. Budget 2.4 mill. Sparrow Quantum (SQ) er en førende udbyder af enkelt-foton-kilder ved 950 nm. Virksomheden har leveret til forskningsgrupper og kvantecomputerudviklere, og vil nu udvide sin produktportefølje for at kunne imødekomme kvantekommunikationsindustrien. For at træde ind på dette marked er en effektiv deterministisk kilde til højkvalitets enkeltfotoner ved 1310 nm (O-båndet), afgørende. Projektet sigter mod at udvikle en sådan kilde og derved spille en afgørende rolle i kvantekommunikationsmarkedet. Partners University of Copenhagen, Sparrow Quantum ApS People Read more about the project
Development of a therapeutic HER2 based vaccine against breast cancer	2019 - 2022	Industrial Researcher
Development of a therapeutic HER2 based vaccine against breast cancer Period 2019 - 2022 Region Region Hovedstaden Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 45.3 Invested 1.2 mill. Budget 2.7 mill. Partners University of Copenhagen, AdaptVac ApS People AdaptVac ApS Read more about the project
Development of a translational mouse model of diabetic heart disease	2021 - 2025	Industrial Researcher
Development of a translational mouse model of diabetic heart disease Period 2021 - 2025 Region Region Hovedstaden Program Erhvervsforsker Area Ikke defineret Investment Percentage 53.73 Invested 1.1 mill. Budget 2.0 mill. Partners University of Copenhagen, GUBRA ApS People GUBRA ApS Read more about the project
Development of a translational rat model of non-alcoholic steatohepatitis (NASH) with liver fibrosis	2021 - 2023	Industrial Researcher
Development of a translational rat model of non-alcoholic steatohepatitis (NASH) with liver fibrosis Period 2021 - 2023 Region Region Hovedstaden Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 100 Invested 1.1 mill. Budget 1.1 mill. Partners University of Copenhagen, GUBRA ApS People GUBRA ApS Read more about the project
Development of advanced interconnects for solid oxide cell stacks.	2020 - 2023	Industrial Researcher
Development of advanced interconnects for solid oxide cell stacks. Period 2020 - 2023 Region Region Hovedstaden Program Erhvervsforsker Area Energi, Klima og Miljø Investment Percentage 100 Invested 1.1 mill. Budget 1.1 mill. Partners Technical University of Denmark, Topsoe A/S People Topsoe A/S Read more about the project
Development of an 131I-labeled FAP targeting radiopharmaceutical to treat triple negative breast cancer	2024 - 2026	Industrial Researcher
Development of an 131I-labeled FAP targeting radiopharmaceutical to treat triple negative breast cancer Period 2024 - 2026 Region Program Erhvervsforsker Area Ikke defineret Investment Percentage 40.89 Invested 828.000 Budget 2.0 mill. Triple-negative breast cancer represents 15-20% of breast cancers and it is the most challenging sub-type to treat. There is currently no good treatment for TNBC. Patients with TNBC have a much shorter survival period once distant metastases have occurred. In this project, we will develop a therapeutic radiopharmaceutical (RP) that targets TNBC, including its metastases, and irradiates it. Our drug will be based on a fibroblast activation protein targeting moiety radiolabeled with iodine-131. Partners University of Copenhagen, Tetrakit Technologies ApS People Read more about the project
Development of an immune modulating cancer vaccine targeting CCL22	2020 - 2023	Industrial Researcher
Development of an immune modulating cancer vaccine targeting CCL22 Period 2020 - 2023 Region Region Hovedstaden Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 36.05 Invested 1.1 mill. Budget 3.0 mill. Partners University of Copenhagen, IO BIOTECH ApS People IO BIOTECH ApS Read more about the project
Development of analytical application by direct spectroscopy (FTIR: NIR: UV-VIS) for optimizing red wine production in regard to the phenolic composition	2017 - 2020	Industrial Researcher
Development of analytical application by direct spectroscopy (FTIR: NIR: UV-VIS) for optimizing red wine production in regard to the phenolic composition Period 2017 - 2020 Region Region Hovedstaden Program Erhvervsforsker Area Produktion, Materialer, Digitalisering og IKT Investment Percentage 58.79 Invested 1.3 mill. Budget 2.2 mill. Partners FOSS ANALYTICAL A/S People FOSS ANALYTICAL A/S Read more about the project
Development of Aquaporin Inside™ technology for Osmotic Membrane Bioreactors	2018 - 2021	Industrial Researcher
Development of Aquaporin Inside™ technology for Osmotic Membrane Bioreactors Period 2018 - 2021 Region Region Hovedstaden Program Erhvervsforsker Area Energi, Klima og Miljø Investment Percentage 56.3 Invested 1.1 mill. Budget 1.9 mill. Partners Technical University of Denmark, AQUAPORIN A/S People AQUAPORIN A/S Read more about the project
Development of artificial ear for bone-conducted sound and vibration measurements	2025 - 2028	Industrial Researcher
Development of artificial ear for bone-conducted sound and vibration measurements Period 2025 - 2028 Region Program Erhvervsforsker Area Ikke defineret Investment Percentage 51.19 Invested 1.1 mill. Budget 2.1 mill. Dette industrielle Ph.d.projekt vil udvikle en kunstig øregang til test af knogleleddets okklusionseffekt. Projektet vil fokusere på at opnå dybdegående viden om effekten af øregangsvibrationer og udvikle en simuleringsmodel samt en prototype til måling af okklusionseffekten forårsaget af transmission gennem knogle-brusk. Projektet er innovativt og adresserer begrænsningerne ved eksisterende værktøjer. Det har potentialet til at yde et væsentligt bidrag til audiologi og beslægtede industrier. Partners GN HEARING A/S, Technical University of Denmark People Technical University of Denmark Read more about the project
Development of Clinical Applications for Evosep One	2021 - 2023	Industrial Researcher
Development of Clinical Applications for Evosep One Period 2021 - 2023 Region Region Syddanmark Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 100 Invested 1.2 mill. Budget 1.2 mill. Partners University of Southern Denmark, Evosep ApS People Evosep ApS Read more about the project